Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol vs Metoprolol in Peripheral Arterial Occlusive Disease
2005-003583-31Phase 3Completed
- Sponsor
- Berlin-Chemie AG
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in peripheral artery occlusion (PAD) and intermittent claudication (IC) comparing Nebivolol (Nebilet) with Metoprolol succinate (Beloc Zok) (2 arms). Primary endpoint: Primary efficacy endpoint. Started Oct 2006; status: completed.
02
Drugs
nebivololCormet
03
Conditions
peripheral artery occlusion (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on 2005-003583-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003583-31.